companydata.dkcompanydata.dk

Vitality Therapeutics ApS: Financial statements 2022

CVR: 39913003

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Vitality Therapeutics ApS (CVR 39913003) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 389,522 and a net result of DKK 300,062 compared with DKK 0 the year before. Equity in the 2022 report amounted to DKK 333,142. The solvency ratio was 77.6%.

Gross Profit
DKK 389,522
Profit/Loss
DKK 300,062
Equity
DKK 333,142
Total Assets
DKK 429,521

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-390K300K333K-
2021-0033K-
2020-00-7K-
2019-00-7K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Vitality Therapeutics ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Vitality Therapeutics ApS: The 2021 annual report is outJun 27, 2022

Vitality Therapeutics ApS has published its annual report for 2021. Gross profit came to DKK 0, and the net result was DKK 0.

Darius Moravcik Holding ApS changes name to Vitality Therapeutics ApSJun 27, 2022

On June 27, 2022, the company changed its name from Darius Moravcik Holding ApS to Vitality Therapeutics ApS.

About Vitality Therapeutics ApS

Vitality Therapeutics ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company has been dissolved on 24 February 2025. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Darius Moravcik Holding ApS and Darius Moravcik Holding IVS. In 2023, the company reported a gross profit of DKK -329,086 and a net result of DKK -327,857 compared with DKK 300,062 the year before. Equity in the 2023 report amounted to DKK 126,219.

Source: annual report 2023, Danish Business Authority

Other financial years